News Release 17-Dec-2024 "EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV)." www.eurekalert.org/news-release... - ThreadSky

About ThreadSky

tomkindlon.bsky.social • 73 days ago

News Release 17-Dec-2024

"EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV)."

https://www.eurekalert.org/news-releases/1068503

Comments

khvmd.bsky.social•73 days ago

Sign me up!

khvmd.bsky.social•73 days ago

On the DZIF site they describe ME/CFS as a Long Covid-like illness. First time I’ve ever seen that. How did LC become the benchmark when it’s really the other way around? Wonder if this vax will help ppl who already have ME/CFS and high EBV titers?

lifeatthewindow.bsky.social•73 days ago

This is good news! Hopefully it all happens and people will be spared the most harmful consequences of the virus.

andrewg76201347.bsky.social•73 days ago

Would be great if this works. Teenage son hasn’t had EBV & the last thing he needs is to add it into his MECFS + POTS + MCAS + Hashimoto’s mix!

philbertblu.bsky.social•72 days ago

in plain speak, is this development for a vax against EBV ?

swalexander.bsky.social•72 days ago

Wow, that's exciting news—thanks for sharing! I couldn't find any explanation on how this might benefit those who are already affected by EBV.

Posting Rules

Be respectful to others
No spam or self-promotion
Stay on topic
Follow Bluesky's terms of service

Comments

Posting Rules

Reply